🧬Exosomes are extracellular vesicles that are generating enormous excitement in regenerative aesthetics. These vesicles contain proteins, cytokines, messenger RNA and microRNA that can influence cellular repair, collagen synthesis, and inflammation modulation. In theory, they could help us “upload new software” to tired or damaged skin.
🧬Used wisely, exosomes offer potential breakthroughs in non-cellular regenerative treatments for skin, scalp, and more. But right now, the hype is outpacing the hard science.
🧬Many so-called “exosome” products don’t contain purified exosomes at all, just cellular debris or extracellular vesicles. Others may be contaminated, unstable, or improperly stored, leading to unpredictable outcomes. Some products are promoted for injectable use without regulatory approval or clinical backing, which is not only risky but illegal in many countries, including South Africa.
🧬As practitioners, we must ask:
- Is it truly purified?
- What’s the exosome concentration?
- Has the product undergone transcript testing?
- Is there peer-reviewed data to support its claims?
🧬The FDA currently requires an IND (Investigational New Drug) application for any injectable exosome use. Most topicals fall under cosmetic regulations, but even here, purity, sourcing, and stability are critical.
🧬Exosomes have a promising future, but the path forward requires
effective leadership and standards. With validated science, rigorous quality controls, and responsible innovation, they may one day rival neurotoxins in market scale and effectiveness.
🧬Until then, we should remain curious, cautious, and committed to evidence-based care.
Sourced from Aesthetic Insight May 2015.